Technical Analysis for IGXT - Intelgenx Technologs

Grade Last Price % Change Price Change
grade C 0.55 1.81% 0.0098
IGXT closed up 1.81 percent on Friday, December 6, 2019, on 39 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical IGXT trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
20 DMA Resistance Bearish 1.81%
Fell Below 200 DMA Bearish 1.81%
Narrow Range Bar Range Contraction 1.81%
NR7 Range Contraction 1.81%
Inside Day Range Contraction 1.81%
20 DMA Resistance Bearish -0.90%
Crossed Above 200 DMA Bullish -0.90%
MACD Bullish Signal Line Cross Bullish -0.90%
Older signals for IGXT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


IntelGenx is a leading drug delivery company focused on the development of innovative products based on its proprietary oral drug delivery technologies. Established in 2003, the Montreal-based company, listed on the TSX-V and OTC-QX, develops innovative oral drug delivery solutions based on its proprietary platform technologies, VersaFilmTM, VersaTabTM and AdVersaTM. IntelGenx has developed a broad and diverse product portfolio addressing unmet market needs and offering lifecycle management opportunities. Forfivo XLTM, launched in 2012, is the first and only FDA approved once-daily bupropion HCl 450mg dose in a single tablet for the treatment of major depressive disorder. IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, clinical monitoring, IP protection, analytical method development and regulatory services. IntelGenx state-of-the art manufacturing facility, established for the VersaFilmTM technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at:
Chemistry Drugs Pharmaceutical Industry In China Psychoactive Drugs Drug Delivery Food And Drug Administration Fda Chloroarenes Major Depressive Disorder Platform Technologies Pharmaceutical Partners Anorectics Nicotinic Antagonists Regulatory Services Treatment Of Major Depressive Disorder

Is IGXT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.799
52 Week Low 0.3901
Average Volume 110,641
200-Day Moving Average 0.5463
50-Day Moving Average 0.5963
20-Day Moving Average 0.5467
10-Day Moving Average 0.5372
Average True Range 0.0344
ADX 10.67
+DI 20.9254
-DI 20.7586
Chandelier Exit (Long, 3 ATRs ) 0.5768
Chandelier Exit (Short, 3 ATRs ) 0.6035
Upper Bollinger Band 0.5997
Lower Bollinger Band 0.4937
Percent B (%b) 0.53
BandWidth 19.3891
MACD Line -0.0119
MACD Signal Line -0.0146
MACD Histogram 0.0027
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.5799
Resistance 3 (R3) 0.5765 0.5633 0.5749
Resistance 2 (R2) 0.5633 0.5557 0.5649 0.5732
Resistance 1 (R1) 0.5566 0.5510 0.5600 0.5600 0.5716
Pivot Point 0.5434 0.5434 0.5450 0.5450 0.5434
Support 1 (S1) 0.5367 0.5358 0.5401 0.5401 0.5284
Support 2 (S2) 0.5235 0.5311 0.5251 0.5268
Support 3 (S3) 0.5168 0.5235 0.5251
Support 4 (S4) 0.5202